COVID-19 and Postinfection Immunity Limited Evidence, Many Remaining Questions
Open Access
- 10 May 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (22), 2245-2246
- https://doi.org/10.1001/jama.2020.7869
Abstract
This Viewpoint describes what is currently known about the immune response to coronavirus disease 2019 (COVID-19), highlights important gaps in knowledge, and iThis publication has 9 references indexed in Scilit:
- False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrenceJournal of Medical Virology, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeJAMA, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020Eurosurveillance, 2020
- Persistence of Antibodies against Middle East Respiratory Syndrome CoronavirusEmerging Infectious Diseases, 2016
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007
- Coronaviruses and TorovirusesPublished by Wiley ,2004